OPEN QUESTIONS OF PSYCHOTIC DEPRESSION

References

1. Jääskeläinen E., Juola T., Korpela H. et al. Epidemiology of psychotic depression – systematic review and meta-analysis // Psychological Medicine. – 2018. – Vol. 48 (6). – Рp. 905–918. – https://doi.org/10.1017/S0033291717002501
2. Ohayon M.M., Schatzberg A.F. Prevalence of depressive episodes with psychotic features in the general population // Am J Psychiatry. – 2002. – Vol. 159 (11). – Рp. 1855–1861. – https://doi.org/10.1176/appi.ajp.159.11.1855
3. Rothschild A.J. Challenges in the treatment of major depressive disorder with psychotic features // Schizophr Bull. – 2013. – Vol. 39 (4). – Рp. 787–796. – https://doi.org/10.1093/schbul/sbt046
4. Costa F.B.P.D., Trachtenberg E., Boni A., Primo de Carvalho Alves L., Magalhães P.V.D.S., Rocha N.S. Psychotic depression in hospitalized patients: Longitudinal outcomes of psychotic vs. nonpsychotic depression among inpatients // J Psychiatr Res. – 2020. – Vol. 129. – Pp. 73–79. – https://doi.org/10.1016/j.jpsychires.2020.06.002
5. Flint A.J., Meyers B.S., Rothschild A.J., Whyte E.M., Mulsant B.H., Rudorfer M.V., Marino P., STOP-PD II Study Group. Sustaining remission of psychotic depression: rationale, design and methodology of STOP-PD II // BMC Psychiatry. – 2013. – Vol. 25. – 38. – https://doi.org/10.1186/1471-244X-13-38
6. Vythilingam M., Chen J., Bremner J.D., Mazure C.M., Maciejewski P.K., Nelson J.C. Psychotic depression and mortality // Am J Psychiatry. – 2003. – Vol. 160 (3). – Pp. 574–576. – https://doi.org/10.1176/appi.ajp.160.3.574
7. Paljärvi T., Tiihonen J., Lähteenvuo M., Tanskanen A., Fazel S., Taipale H. Mortality in psychotic depression: 18-year follow-up study // The British Journal of Psychiatry. – 2023. – Vol. 222 (1). – Pp. 37–43. – https://doi.org/10.1192/bjp.2022.140
8. Петрова Н.Н., Столяров А.Р. Психотическая депрессия с позиции персонифицированного подхода // Российский психиатрический журнал. – 2021. – № 1. – С. 82–92. – https://doi.org/10.47877/1560-957X-2021-10109
9. Dubovsky S.L., Ghosh B.M., Serotte J.C., Cranwell V. Psychotic Depression: Diagnosis, Differential Diagnosis, and Treatment // Psychother Psychosom. – 2021. – Vol. 90 (3). – Pp. 160–177. – https://doi.org/10.1159/000511348
10. Tandon R. Conceptualizing psychotic disorders: don’t throw the baby out with the bathwater // World Psychiatry. – 2016. – Vol. 15 (2). – Pp. 133–34. – https://doi.org/10.1002/wps.20338
11. Morgan C., Lappin J., Heslin M., Donoghue K., Lomas B., Reininghaus U., Onyejiaka A., Croudace T., Jones P.B., Murray R.M., Fearon P., Doody G.A., Dazzan P. Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study // Psychol Med. – 2014. – Vol. 44 (13). – Pp. 2713–2726. – https://doi.org/10.1017/S0033291714000282
12. van Os J., Reininghaus U. Psychosis as a transdiagnostic and extended phenotype in the general population//World Psychiatry. – 2016. – Vol. 15 (2). – Pp. 118–124. – https://doi.org/10.1002/wps.20310
13. Keller J., Schatzberg A. F., Maj M. Current Issues in the Classification of Psychotic Major Depression // Schizophr Bull. – 2007. – Vol. 33. – Pр. 877–885. – https://doi.org/10.1093/schbul/sbm065
14. Nelson J.C., Bickford D., Delucchi K., Fiedorowicz J.G., Coryell W.H. Risk of psychosis in recurrent episodes of psychotic and nonpsychotic major depressive disorder: a systematic review and meta-analysis // Am J Psychiatry. – 2018. – Vol. 175. – Pp. 897–904. https://doi.org/10.1176/appi.ajp.2018.17101138
15. Heslin M., Lomas B., Lappin J.M., Donoghue K., Reininghaus U., Onyejiaka A. et al. Diagnostic change 10 years after a first episode of psychosis // Psychol Med. – 2015. – Vol. 45. – Pp. 2757–2769. – https://doi.org/10.1017/S0033291715000720
16. McGorry P.D., Hartmann J.A., Spooner R., Nelson B. Beyond the “at risk mental state” concept: Transitioning to transdiagnostic psychiatry // World Psychiatry. – 2018. – Vol. 17 (2). – Pp. 133–142. – https://doi.org/10.1002/wps.20514
17. Heslin M., Young A.H. Psychotic major depression: challenges in clinical practice and research // The British Journal of Psychiatry. – 2018. – Vol. 212. – Pp. 131–133. https://doi.org/10.1192/bjp.2017.43
18. Ruggero C.J., Kotov R., Carlson G.A., Tanenberg-Karant M., González D.A., Bromet E.J. Diagnostic consistency of major depression with psychosis across 10 years // J Clin Psychiatry. – 2011. – Vol. 72 (9). – Pp. 1207–1213. – https://doi.org/10.4088/JCP.10m06774
19. Østergaard S.D., Pedersen C.H., Uggerby P., Munk-Jørgensen P., Rothschild A.J., Larsen J.I., Gøtzsche C., Søndergaard M.G., Bille A.G., Bolwig T.G., Larsen J.K., Bech P. Clinical and psychometric validation of the psychotic depression assessment scale // J Affect Disord. – 2015. – Vol. 1 (173). – Pp. 261–268. – https://doi.org/10.1016/j.jad.2014.11.012
20. Carlson G.A. Affective disorders and psychosis in youth // Child Adolesc Psychiatr Clin N Am. – 2013. – Vol. 22 (4). – Pp. 569–580. – https://doi.org/10.1016/j.chc.2013.04.003
21. Wijkstra J., Burger H., van den Broek W.W., Birkenhäger T.K., Janzing J.G., Boks M.P., Bruijn J.A., van der Loos M.L., Breteler L.M., Verkes R.J., Nolen W.A. Long-term response to successful acute pharmacological treatment of psychotic depression // J Affect Disord. – 2010. – Vol. 123 (1–3). – Pp. 238–242. – https://doi.org/10.1016/j.jad.2009.10.014
22. Tohen M., Khalsa H.K., Salvatore P., Vieta E., Ravichandran C., Baldessarini R.J. Two-year outcomes in first-episode psychotic depression the McLean-Harvard First-Episode Project // J Affect Disord. – 2012. – Vol. 136 (1–2). – Pp. 1–8. – https://doi.org/10.1016/j.jad.2011.08.028
23. Coryell W., Leon A., Winokur G., Endicott J., Keller M., Akiskal H., Solomon D. Importance of psychotic features to long-term course in major depressive disorder // Am J Psychiatry. – 1996. – Vol. 153 (4). – Pp. 483–489. – https://doi.org/10.1176/ajp.153.4.483
24. Биологические методы терапии психических расстройств (доказательная медицина – клинической практике) / под ред. С.Н. Мосолова. – М.: Социально-политическая мысль, 2012. – 1073 с.
25. Мосолов С.Н., Костюкова Е.Г. Лечение больных с рекуррентным депрессивным расстройством // Психиатрия: национальное руководство / под ред. Н.Г. Незнанова, Ю.А. Александровского. – М.: Эхо, 2018. – С. 347–378.
26. Farahani A., Correll C.U. Are antipsychotics or antidepressants needed for psychotic depression? A systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment // J Clin Psychiatry. – 2012. – Vol. 73 (4). – Рp. 486–496. – https://doi.org/10.4088/JCP.11r07324
27. Anthonis E., Sienaert P. Farmacotherapeutische behandeling van psychotische depressie: een overzicht [Farmacotherapeutic treatment of psychotic depression: a review] // Tijdschr Psychiatr. – 2021. – Vol. 63 (5). – Pp. 358–365. – PMID: 34043225
28. Gabriel A. Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study // Neuropsychiatr Dis Treat. – 2013. – Vol. 9. – Pp. 485–492. – https://doi.org/10.2147/NDT.S42745
29. König F., Hippel C.V., Petersdorff T., Neuhöffer-Weiss M., Wolfersdorf M., Kaschka W.P. First experiences in combination therapy using olanzapine with SSRIs (citalopram, paroxetine) in delusional depression // Neuropsychobiology. – 2001. – Vol. 43. – Pp. 170– 174. – https://doi.org/10.1159/000054886
30. Konstantinidis A., Hrubos W., Nirnberger G., Windhager E., Lehofer M., Aschauer H. et al. Quetiapine in combination with citalopram in patients with unipolar psychotic depression // Prog Neuropsychopharmacol Biol Psychiatry. – 2007. – Vol. 31. – Pp. 242–247. – https://doi.org/10.1016/j.pnpbp.2006.07.002
31. Matthews J.D., Bottonari K.A., Polonia L.M., Mischoulon D., Dording C.M., Irvin R. et al. An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses // J Clin Psychiatry. – 2002. – Vol. 63. – Pp. 1164–1170. – https://doi.org/10.4088/jcp.v63n1212
32. Meyers B.S., Flint A.J., Rothschild A.J., Mulsant B.H. A double-blind randomized controlled trial of olanzapine plus sertraline versus olanzapine plus placebo for psychotic depression – the stop-PD study // Arch Gen Psychiatry. – 2009. – Vol. 66. – Pp. 838–847. – https://doi.org/10.1001/archgenpsychiatry.2009.79
33. Депрессивный эпизод. Рекуррентное депрессивное расстройство. Клинические рекомендации. Взрослые // Электронное издание. М.: Минздрав РФ, 2021. – 89 с. – URL: https://cr.minzdrav.gov.ru/recomend/301_2 (дата обращения 12.02.2023).
34. Mendlewicz J. Efficacy of fluvoxamine in severe depression// Drugs. – 1992. – Vol. 43 (2). – P. 32–37; discussion 37-9. – https://doi.org/10.2165/00003495-199200432-00006
35. Gatti F., Bellini L., Gasperini M., Perez J., Zanardi R., Smeraldi E. Fluvoxamine alone in the treatment of delusional depression // Am J Psychiatry. – 1996. – Vol. 153 (3). – Pp. 414–416. – https://doi.org/10.1176/ajp.153.3.414
36. Zanardi R., Franchini L., Gasperini M., Smeraldi E., Perez J. Longterm treatment of psychotic (delusional) depression with fluvoxamine: an open pilot study // Int Clin Psychopharmacol. – 1997. – Vol. 12 (4). – Pp. 195–197. – https://doi.org/10.1097/00004850-199707000-00002
37. Hedlund J.L., Vieweg B.W. The Hamilton rating scale for depression: A comprehensive review // Journal of Operational Psychiatry. – 1979. – Vol. 10. – Pp. 149–165.
38. Kendler K.S., Glazer W.M., Morgenstern H. Dimensions of delusional experience // Am J Psychiatry. – 1983. – Vol. 140 (4). – Pp. 466–469. – https://doi.org/10.1176/ajp.140.4.466
39. Zanardi R., Franchini L., Gasperini M., Lucca A., Smeraldi E., Perez J. Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: a controlled study // J Clin Psychopharmacol. – 1998. – Vol. 18 (6). – Pp. 441–446. – https://doi.org/10.1097/00004714-199812000-00004
40. Bellini L., Gasperini M., Gatti F., Franchini L., Smeraldi E. A double blind study with fluvoxamine vs. desipramine combined with placebo or haloperidol in delusional depression // Crit Issues Treat Affect Disord. –1994. – Vol. 9. – Pp. 32–36.
41. Zanardi R., Franchini L., Serretti A., Perez J., Smeraldi E. Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study // J Clin Psychiatry. – 2000. – Vol. 61 (1). – Pp. 26–29. – https://doi.org/10.4088/jcp.v61n0107
42. Furuse T., Hashimoto K. Fluvoxamine monotherapy for psychotic depression: the potential role of sigma-1 receptors // Ann Gen Psychiatry. – 2009. – Vol. 21 (8). – Art. 26. – https://doi.org/10.1186/1744-859X-8-26
43. Stahl S.M. Antidepressant treatment of psychotic major depression: potential role of the sigma receptor // CNS Spectr. – 2005. – Vol. 10 (4). – Pp. 319–323. – https://doi.org/10.1017/s1092852900022641
44. Fishback J.A., Robson M.J., Xu Y.T., Matsumoto R.R. Sigma receptors: potential targets for a new class of antidepressant drug // Pharmacol Ther. – 2010. – Vol. 127 (3). – Pp. 271–282. – https://doi.org/10.1016/j.pharmthera.2010.04.003
45. Albayrak Y., Hashimoto K. Sigma-1 Receptor Agonists and Their Clinical Implications in Neuropsychiatric Disorders // Adv Exp Med Biol. – 2017. – Vol. 964. – Pp. 153–161. – https://doi.org/10.1007/978-3-319-50174-1_11
46. Smith S.B. Introduction to Sigma Receptors: Their Role in Disease and as Therapeutic Targets // Adv Exp Med Biol. – 2017. – Vol. 964. – Pp. 1–4. – https://doi.org/10.1007/978-3-319-50174-1
47. Morales-Lázaro S.L., González-Ramírez R., Rosenbaum T. Molecular Interplay Between the Sigma-1 Receptor, Steroids, and Ion Channels // Front Pharmacol. – 2019. – Vol. 24 (10). – Art. 419. – https://doi.org/10.3389/fphar.2019.00419
48. Kishimoto A., Todani A., Miura J., Kitagaki T., Hashimoto K. The opposite effects of fluvoxamine and sertraline in the treatment of psychotic major depression: a case report // Ann Gen Psychiatry. – 2010. – Vol. 21 (9). – Art. 23. – https://doi.org/10.1186/1744-859X-9-23
49. Serretti A., Lattuada E., Zanardi R., Franchini L., Smeraldi E. Patterns of symptom improvement during antidepressant treatment of delusional depression // Psychiatry Res. – 2000. – Vol. 94 (2). – Pp. 185–190. – https://doi.org/10.1016/s0165-1781(00)00139-6
50. Kelstrup A.M., Videbech P. [Unipolar psychotic depression] // Ugeskr Laeger. – 2021. – Vol. 183 (38). – Art. V04210312.